<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39384231</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy.</ArticleTitle><Pagination><StartPage>e084669</StartPage><MedlinePgn>e084669</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e084669</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2024-084669</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To describe the development, validation and reliability of the Oxford Vaccine Hesitancy Scale (OVHS), a new instrument to assess vaccine hesitancy in the general population.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cross-sectional validation study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Internet-based study with participants in the UK and USA.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Demographically representative (stratified by age, sex and race) samples from the UK and USA recruited through the Prolific Academic platform.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">To demonstrate OVHS development, exploratory factor analysis with categorical variables and a polychoric correlation matrix followed by promax oblique rotation on the UK sample was performed. Confirmatory factor analysis with a Satorra-Bentler scaled test statistic evaluating goodness of fit statistics including the root mean squared error of approximation (RMSEA), standardised root mean squared residual (SRMR) and comparative fit index (CFI) was performed on the US sample. Reliability as internal consistency was assessed using McDonald's omega. Evidence in support of the predictive, convergent and discriminant validity of the scale was assessed using logistic regression ORs of association (OR) or Pearson correlation coefficients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data for factor analysis were obtained from 1004 respondents, 504 in the UK and 500 in the USA. A scree plot, minimum average partial correlation analysis and parallel analysis suggested a three-factor 13-item scale with domains of vaccine beliefs (seven items), pain (three items) and personal deliberation (three items). Responses were recorded on a Likert scale ranging from disagree completely to agree completely, with higher score reflecting greater hesitancy. Potential total scores ranged from 13 to 65. Goodness of fit was excellent, with RMSEA=0.044, SRMR=0.041 and CFI=0.977. Predictive validity for COVID-19 vaccination status was excellent, with logistic regression ORs of association (95% CI) of 0.07 (0.04, 0.13), p&lt;0.0001 for the UK sample for each SD increase in OVHS score, suggesting a 93% decrease in the odds of being vaccinated against COVID-19 for each SD increase in OVHS score. Convergent validity between the OVHS score and the 5C short version scale demonstrated a correlation coefficient of 0.32 (p&lt;0.0001). Discriminant validity with an unrelated desire to perform outdoor activities demonstrated an OR (95% CI) of 1.06 (0.88, 1.29), p=0.523 for the UK sample for each SD increase in OVHS score. McDonald's omega was 0.86 and 0.87 in the UK and US samples, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The OVHS is a feasible, valid and reliable scale for assessing vaccine hesitancy; further testing is warranted.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kantor</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3256-3014</Identifier><AffiliationInfo><Affiliation>Oxford Vaccine Group, University of Oxford, Oxford, UK jonkantor@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Engineering Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlisle</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Engineering Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>HeLEX - Centre for Health, Law and Emerging Technologies, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollard</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-7361-719X</Identifier><AffiliationInfo><Affiliation>Oxford Vaccine Group, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderslott</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Oxford Vaccine Group, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="Y">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="Y">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005163" MajorTopicYN="N">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PUBLIC HEALTH</Keyword><Keyword MajorTopicYN="N">Public health</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39384231</ArticleId><ArticleId IdType="pmc">PMC11474876</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2024-084669</ArticleId><ArticleId IdType="pii">bmjopen-2024-084669</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper S, Wiysonge CS. Towards a more critical public health understanding of vaccine hesitancy: key insights from a decade of researchMore Critical Public Health Understanding of Vaccine Hesitancy: Key Insights from a Decade of Research. Vaccines (Basel) 2023;11:1155. doi: 10.3390/vaccines11071155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11071155</ArticleId><ArticleId IdType="pmc">PMC10386194</ArticleId><ArticleId IdType="pubmed">37514971</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon DA, Dudley MZ, Glanz JM. Vaccine hesitancy: causes, consequences, and a call to action. Vaccine (Auckl) 2015;33 Suppl 4:D66–71. doi: 10.1016/j.vaccine.2015.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.09.035</ArticleId><ArticleId IdType="pubmed">26615171</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskola J, Duclos P, Schuster M, et al. How to deal with vaccine hesitancy? Vaccine (Auckl) 2015;33:4215–7. doi: 10.1016/j.vaccine.2015.04.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.043</ArticleId><ArticleId IdType="pubmed">25896378</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubé È, MacDonald NE. Managing the risks of vaccine hesitancy and refusals. Lancet Infect Dis. 2016;16:518–9. doi: 10.1016/S1473-3099(16)00028-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)00028-1</ArticleId><ArticleId IdType="pubmed">26852724</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Child &amp; Adolescent Health Vaccine hesitancy: a generation at risk. Lancet Child Adolesc Health. 2019;3:281. doi: 10.1016/S2352-4642(19)30092-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30092-6</ArticleId><ArticleId IdType="pubmed">30981382</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Ten threats to global health in 2019. 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 Available.</Citation></Reference><Reference><Citation>Lazarus JV, Wyka K, White TM, et al. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun. 2022;13:3801. doi: 10.1038/s41467-022-31441-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31441-x</ArticleId><ArticleId IdType="pmc">PMC9247969</ArticleId><ArticleId IdType="pubmed">35778396</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaghan T, Washburn D, Goidel K, et al. Imperfect Messengers? An Analysis of Vaccine Confidence among Primary Care Physicians. Elsevier Science; 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8931689</ArticleId><ArticleId IdType="pubmed">35315324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadwick A, Kaiser J, Vaccari C, et al. Online social endorsement and covid-19 vaccine hesitancSocial Endorsement and Covid-19 Vaccine Hesitancy in the United Kingdom. Soc Media + Soc. 2021;7:205630512110088. doi: 10.1177/20563051211008817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20563051211008817</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenkel LD. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better? Allergy Asthma Proc. 2021;42:378–85. doi: 10.2500/aap.2021.42.210065.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2021.42.210065</ArticleId><ArticleId IdType="pmc">PMC8677503</ArticleId><ArticleId IdType="pubmed">34474707</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussink-Voorend D, Hautvast JLA, Vandeberg L, et al. A systematic literature review to clarify the concept of vaccine hesitancy. Nat Hum Behav. 2022;6:1634–48. doi: 10.1038/s41562-022-01431-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-022-01431-6</ArticleId><ArticleId IdType="pubmed">35995837</ArticleId></ArticleIdList></Reference><Reference><Citation>Oduwole EO, Pienaar ED, Mahomed H, et al. Overview of tools and measures investigating vaccine hesitancy in a ten year period: a scoping reviewTools and Measures Investigating Vaccine Hesitancy in a Ten Year Period: A Scoping Review. Vaccines (Basel) 2022;10:1198. doi: 10.3390/vaccines10081198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081198</ArticleId><ArticleId IdType="pmc">PMC9412526</ArticleId><ArticleId IdType="pubmed">36016086</ArticleId></ArticleIdList></Reference><Reference><Citation>Opel DJ, Taylor JA, Mangione-Smith R, et al. Validity and reliability of a survey to identify vaccine-hesitant parents. Vaccine (Auckl) 2011;29:6598–605. doi: 10.1016/j.vaccine.2011.06.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.06.115</ArticleId><ArticleId IdType="pubmed">21763384</ArticleId></ArticleIdList></Reference><Reference><Citation>Opel DJ, Mangione-Smith R, Taylor JA, et al. Development of a survey to identify vaccine-hesitant parents: the parent attitudes about childhood vaccines survey. Hum Vaccin. 2011;7:419–25. doi: 10.4161/hv.7.4.14120.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.7.4.14120</ArticleId><ArticleId IdType="pmc">PMC3360071</ArticleId><ArticleId IdType="pubmed">21389777</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson HJ, Jarrett C, Schulz WS, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine (Auckl) 2015;33:4165–75. doi: 10.1016/j.vaccine.2015.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.037</ArticleId><ArticleId IdType="pubmed">25896384</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilkey MBP, Reiter PLP, Magnus B, et al. Validation of the vaccination confidence scale: a brief measure to identify parents at risk for refusing adolescent vaccineVaccination Confidence Scale: A Brief Measure to Identify Parents at Risk for Refusing Adolescent Vaccines. Acad Pediatr. 2016;16:42–9. doi: 10.1016/j.acap.2015.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acap.2015.06.007</ArticleId><ArticleId IdType="pmc">PMC4715593</ArticleId><ArticleId IdType="pubmed">26300368</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilkey MB, Magnus BE, Reiter PL, et al. The vaccination confidence scale: a brief measure of parents’ vaccination beliefsVaccination Confidence Scale: a brief measure of parents’ vaccination beliefs. Vaccine (Auckl) 2014;32:6259–65. doi: 10.1016/j.vaccine.2014.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.09.007</ArticleId><ArticleId IdType="pmc">PMC4418546</ArticleId><ArticleId IdType="pubmed">25258098</ArticleId></ArticleIdList></Reference><Reference><Citation>Frew PM, Murden R, Mehta CC, et al. Development of a US trust measure to assess and monitor parental confidence in the vaccine system. Vaccine (Auckl) 2019;37:325–32. doi: 10.1016/j.vaccine.2018.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.09.043</ArticleId><ArticleId IdType="pmc">PMC6573024</ArticleId><ArticleId IdType="pubmed">30503657</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LR, Petrie KJ. Understanding the Dimensions of Anti-Vaccination Attitudes: the Vaccination Attitudes Examination (VAX) Scale. Ann Behav Med. 2017;51:652–60. doi: 10.1007/s12160-017-9888-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12160-017-9888-y</ArticleId><ArticleId IdType="pubmed">28255934</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro GK, Tatar O, Dube E, et al. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine (Auckl) 2018;36:660–7. doi: 10.1016/j.vaccine.2017.12.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.12.043</ArticleId><ArticleId IdType="pubmed">29289384</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer NT, Chapman GB, Rothman AJ, et al. Increasing vaccination: putting psychological science into actionVaccination: Putting Psychological Science Into Action. Psychol Sci Public Interest. 2017;18:149–207. doi: 10.1177/1529100618760521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1529100618760521</ArticleId><ArticleId IdType="pubmed">29611455</ArticleId></ArticleIdList></Reference><Reference><Citation>Betsch C, Schmid P, Heinemeier D, et al. Beyond confidence: development Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One. 2018;13:e0208601. doi: 10.1371/journal.pone.0208601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208601</ArticleId><ArticleId IdType="pmc">PMC6285469</ArticleId><ArticleId IdType="pubmed">30532274</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard MC. A more comprehensive measure of vaccine hesitancy: Creation of the Multidimensional Vaccine Hesitancy Scale (MVHS) J Health Psychol. 2022;27:2402–19. doi: 10.1177/13591053211042062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053211042062</ArticleId><ArticleId IdType="pubmed">34474616</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoeckel F, Carter C, Lyons BA, et al. The politics of vaccine hesitancy in Europe. Eur J Public Health. 2022;32:636–42. doi: 10.1093/eurpub/ckac041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckac041</ArticleId><ArticleId IdType="pmc">PMC9341843</ArticleId><ArticleId IdType="pubmed">35522721</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Su M-H, Hwang J, et al. Polarization over vaccination: ideological differences in twitter expression about Over Vaccination: Ideological Differences in Twitter Expression About COVID-19 vaccine favorability and specific hesitancy concern Vaccine Favorability and Specific Hesitancy Concerns. Soc Media + Soc. 2021;7:205630512110484. doi: 10.1177/20563051211048413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20563051211048413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hettinga J, Carlisle R. Vaccination into the dermal compartment: techniques, challenges, and prospectsDermal Compartment: Techniques, Challenges, and Prospects. Vaccines (Basel) 2020;8:534. doi: 10.3390/vaccines8030534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8030534</ArticleId><ArticleId IdType="pmc">PMC7564253</ArticleId><ArticleId IdType="pubmed">32947966</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantor J, Vanderslott S, Morrison M, et al. The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public. BMJ Open. 2023;13:e074466. doi: 10.1136/bmjopen-2023-074466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-074466</ArticleId><ArticleId IdType="pmc">PMC10729041</ArticleId><ArticleId IdType="pubmed">38097240</ArticleId></ArticleIdList></Reference><Reference><Citation>Boateng GO, Neilands TB, Frongillo EA, et al. Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer. Front Public Health. 2018;6:149. doi: 10.3389/fpubh.2018.00149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2018.00149</ArticleId><ArticleId IdType="pmc">PMC6004510</ArticleId><ArticleId IdType="pubmed">29942800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantor BN, Kantor J. Development and validation of the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C): an internet-based cross-sectional study in the UK and USA. BMJ Open. 2021;11:e043758. doi: 10.1136/bmjopen-2020-043758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043758</ArticleId><ArticleId IdType="pmc">PMC8282421</ArticleId><ArticleId IdType="pubmed">34261678</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins MW. A Step-by-Step Guide to Exploratory Factor Analysis with Stata. New York, NY: Routledge; 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.4324/9781003149286</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo-Seva U, Ferrando PJ. MSA: The forgotten index for identifying inappropriate items before computing exploratory item factor analysis. Methodology (Gott) 2021;17:296–306. doi: 10.5964/meth.7185.</Citation><ArticleIdList><ArticleId IdType="doi">10.5964/meth.7185</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinno A. Implementing Horn’s parallel analysis for principal component analysis and factor analysiParallel Analysis for Principal Component Analysis and Factor Analysis. Stata J. 2009;9:291–8. doi: 10.1177/1536867X0900900207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X0900900207</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika. 1965;30:179–85. doi: 10.1007/BF02289447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02289447</ArticleId><ArticleId IdType="pubmed">14306381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelleri JC, Jason Lundy J, Hays RD. Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures. Clin Ther. 2014;36:648–62. doi: 10.1016/j.clinthera.2014.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.04.006</ArticleId><ArticleId IdType="pmc">PMC4096146</ArticleId><ArticleId IdType="pubmed">24811753</ArticleId></ArticleIdList></Reference><Reference><Citation>Holgado–Tello FP, Chacón–Moscoso S, Barbero–García I, et al. Polychoric versus Pearson correlations in exploratory and confirmatory factor analysis of ordinal variables. Qual Quant. 2010;44:153–66. doi: 10.1007/s11135-008-9190-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11135-008-9190-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Flora DB, Curran PJ. An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods. 2004;9:466–91. doi: 10.1037/1082-989X.9.4.466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.9.4.466</ArticleId><ArticleId IdType="pmc">PMC3153362</ArticleId><ArticleId IdType="pubmed">15598100</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne MW, Cudeck R. Alternative Ways of Assessing Model Fit. Sociological Methods &amp; Research . 1992;21:230–58. doi: 10.1177/0049124192021002005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0049124192021002005</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne MW, Cudeck R, Bollen KA, et al. Testing Structural Equation Models. 1993. p. 136.</Citation></Reference><Reference><Citation>Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80:99–103. doi: 10.1207/S15327752JPA8001_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/S15327752JPA8001_18</ArticleId><ArticleId IdType="pubmed">12584072</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido LE, Abad FJ, Ponsoda V. Performance of velicer’s minimum average partial factor retention method with categorical variablesVelicer’s Minimum Average Partial Factor Retention Method With Categorical Variables. Educ Psychol Meas. 2011;71:551–70. doi: 10.1177/0013164410389489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0013164410389489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledesma RD, Valero-Mora P, Macbeth G. The scree test and the number of factors: a dynamic graphics approachScree Test and the Number of Factors: a Dynamic Graphics Approach. Span J Psychol. 2015;18:E11. doi: 10.1017/sjp.2015.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/sjp.2015.13</ArticleId><ArticleId IdType="pubmed">26055575</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathje S, He JK, Roozenbeek J, et al. Social media behavior is associated with vaccine hesitancy. PNAS Nexus . 2022;1:pgac207. doi: 10.1093/pnasnexus/pgac207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgac207</ArticleId><ArticleId IdType="pmc">PMC9802475</ArticleId><ArticleId IdType="pubmed">36714849</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascherini M, Nivakoski S. Social media use and vaccine hesitancy in the European Union. Vaccine (Auckl) 2022;40:2215–25. doi: 10.1016/j.vaccine.2022.02.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.02.059</ArticleId><ArticleId IdType="pmc">PMC8893322</ArticleId><ArticleId IdType="pubmed">35249775</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Understanding the behavioural and social drivers of vaccine uptake WHO position paper – May 2022. Wkly Epidemiol Rec. 2022;97:209–24.</Citation></Reference><Reference><Citation>Sarathchandra D, Navin MC, Largent MA. A survey instrument for measuring vaccine acceptance. Prev Med. 2018;109:1–7. doi: 10.1016/j.ypmed.2018.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2018.01.006</ArticleId><ArticleId IdType="pubmed">29337069</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrion ML. “You need to do your research”: Vaccines, contestable science, and maternal epistemology. Public Underst Sci. 2018;27:310–24. doi: 10.1177/0963662517728024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963662517728024</ArticleId><ArticleId IdType="pubmed">28841813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward PR, Attwell K, Meyer SB, et al. Understanding the perceived logic of care by vaccine-hesitant and vaccine-refusing parents: A qualitative study in Australia. PLoS One. 2017;12:e0185955. doi: 10.1371/journal.pone.0185955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185955</ArticleId><ArticleId IdType="pmc">PMC5638294</ArticleId><ArticleId IdType="pubmed">29023499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E, Baras Y, Buttenheim AM. “Everybody just wants to do what’s best for their child”: Understanding how pro-vaccine parents can support a culture of vaccine hesitancy. Vaccine (Auckl) 2015;33:6703–9. doi: 10.1016/j.vaccine.2015.10.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.090</ArticleId><ArticleId IdType="pmc">PMC5554443</ArticleId><ArticleId IdType="pubmed">26518397</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchsherer A, Jason M, Platt CA, et al. Immunized against science: Narrative community building among vaccine refusing/hesitant parents. Public Underst Sci. 2020;29:419–35. doi: 10.1177/0963662520921537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963662520921537</ArticleId><ArticleId IdType="pubmed">32434461</ArticleId></ArticleIdList></Reference><Reference><Citation>Attwell K, Smith DT, Ward PR. The Unhealthy Other’: How vaccine rejecting parents construct the vaccinating mainstream. Vaccine (Auckl) 2018;36:1621–6. doi: 10.1016/j.vaccine.2018.01.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.01.076</ArticleId><ArticleId IdType="pubmed">29449097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tram KH, Saeed S, Bradley C, et al. Deliberation, dissent, and distrust: understanding distinct drivers of coronavirus disease 2019 vaccine hesitancyDissent, and Distrust: Understanding Distinct Drivers of Coronavirus Disease 2019 Vaccine Hesitancy in the United States. Clin Infect Dis. 2022;74:1429–41.:ciab633. doi: 10.1093/cid/ciab633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab633</ArticleId><ArticleId IdType="pmc">PMC8406882</ArticleId><ArticleId IdType="pubmed">34272559</ArticleId></ArticleIdList></Reference><Reference><Citation>DeWees TA, Mazza GL, Golafshar MA, et al. Investigation Into the effects of using normal distribution theory methodology for likert scale patient-reported outcome data from varying underlying distributions including floor/ceiling effectsEffects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects. V Health. 2020;23:625–31. doi: 10.1016/j.jval.2020.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2020.01.007</ArticleId><ArticleId IdType="pubmed">32389228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Leung S-O. Can likert scales be treated as interval sLikert Scales be Treated as Interval Scales?—a simulation studA Simulation Study. J Soc Serv Res. 2017;43:527–32. doi: 10.1080/01488376.2017.1329775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01488376.2017.1329775</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisinga R, Grotenhuis M te, Pelzer B. The reliability of a two-item scale: Pearson, Cronbach, or Spearman-Brown? Int J Public Health. 2013;58:637–42. doi: 10.1007/s00038-012-0416-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-012-0416-3</ArticleId><ArticleId IdType="pubmed">23089674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilário AP, Scavarda A, Numerato D, et al. Recruiting a hard-to-reach, hidden and vulnerable population: the methodological and practical pitfalls of researching vaccine-hesitant parentsHard-to-Reach, Hidden and Vulnerable Population: The Methodological and Practical Pitfalls of Researching Vaccine-Hesitant Parents. Qual Health Res. 2023;33:1189–202. doi: 10.1177/10497323231196439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10497323231196439</ArticleId><ArticleId IdType="pmc">PMC10626983</ArticleId><ArticleId IdType="pubmed">37671951</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>